Actively Recruiting
Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease.
Led by Central Hospital, Nancy, France · Updated on 2026-02-03
240
Participants Needed
2
Research Sites
265 weeks
Total Duration
On this page
Sponsors
C
Central Hospital, Nancy, France
Lead Sponsor
C
Centre Hospitalier Régional Metz-Thionville
Collaborating Sponsor
AI-Summary
What this Trial Is About
The MICROSPA project aims to compare gut microbiota, serum cytokines, and PBMC of patients suffering from Crohn's disease (CD) associated or not to spondylarthritis (SpA). 3 groups of patients will be analyzed: patients suffering from CD alone, patients suffering from SpA alone, patients suffering from CD and SpA. One group of healthy controls will be analysed as a comparator. Fecal microbiota will be determined by bacteriome, virome and fungome NGS sequencing
CONDITIONS
Official Title
Identification of Fecal Microbiota Biomarkers of Spondyloarthritis in Patients Suffering From Crohn's Disease.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 63 18 years
- Patients diagnosed with Crohn's disease and axial spondyloarthritis
- Patients diagnosed with Crohn's disease alone for at least 3 months with exclusion of spondyloarthritis
- Patients diagnosed with axial spondyloarthritis alone with exclusion of Crohn's disease
- Ability to give informed consent
You will not qualify if you...
- History of colonic resection
- Use of antibiotics or colon preparation within 8 weeks before stool collection
- Presence of an ostomy at the time of stool sampling
- Body mass index (BMI) greater than 30
- Extreme diet
- Unbalanced diabetes
- Pregnancy
- Under legal guardianship, curatorship, or judicial protection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Central Hospital
Nancy, Lorraine, France, 54500
Actively Recruiting
2
Saint Antoine Hospital
Paris, France, 75012
Actively Recruiting
Research Team
L
Laurent MD PEYRIN-BIROULET, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
SCREENING
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here